The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings in an effort to smooth the path to more affordable alternatives to brand-name drugs—including blockbusters ...
The agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it ...
Boehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the ...
The U.S. Federal Trade Commission filed an enforcement action against payment platform Doxo, Steve Shivers and Roger Parks on April 25 in Washington Western District Court. The complaint accuses ...
Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In Part 1 of this exclusive video interview, MedPage Today ...
Subaru was slapped with a patent infringement lawsuit on May 14 in Texas Eastern District Court. The lawsuit was brought by Garteiser Honea PLLC on behalf of Infogation Corp., which targets Subaru ...
As Americans go through their annual ceremony of tax day, Senator Elizabeth Warren (D-MA) has reminded the FTC that tax software biz Intuit is making bank on "junk fees."… The FTC has been after ...
Non-Compete Agreements are contracts, typically formed in employment or business purchase contexts, where one party agrees to refrain from engaging in a particular line of work or pursuing ...
The U.S. Federal Trade Commission expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings pertaining to 20 different brand-name treatments for ...